文献速递病毒性肝炎医院感染防控

2007-2016年美国甲型肝炎病毒易感性分析

Susceptibility to Hepatitis A Virus Infection in the United States, 2007-2016.
PubMed 文献 · Clin Infect Dis · 2020-01-01

研究利用2007-2016年美国国家健康与营养调查数据,估算≥2岁人群甲型肝炎病毒(HAV)易感性(总抗体阴性)患病率。美国出生≥20岁成人HAV易感性为74.1%(95%CI 72.9-75.3%),风险人群中易感性与未接种比例均较高,免疫队列则较低。研究认为需加强成人高危人群疫苗接种以控制疫情。

要点

  • 美国出生≥20岁成人HAV易感性达74.1%,约四分之三成人仍易感。
  • 注射吸毒者、男男性行为者、乙肝或丙肝患者易感性与未接种比例均较高。
  • 免疫队列易感性与未接种随时间下降,风险人群则保持稳定。

核心结论

  • 2007-2016年美国出生成人约四分之三仍对HAV易感,需重点加强高危成人疫苗接种。

研究设计与样本

  • 基于美国国家健康与营养调查2007-2016年数据,估算≥2岁人群HAV易感性患病率。
  • 在美国出生≥20岁成人中分析易感性的患病率、预测因素及年龄标化趋势。

主要发现

  • 美国出生≥20岁成人HAV易感性患病率为74.1%(95%CI 72.9-75.3%)。
  • 易感性预测因素包括30-49岁年龄组、非西班牙裔白人/黑人、贫困线130%以上及无医疗保险。
  • 注射吸毒者HAV易感性与未接种比例分别为72.9%和73.1%。
  • 男男性行为者分别为67.5%和65.2%;乙肝或丙肝患者分别为55.2%和75.1%;免疫队列分别为22.6%和25.9%。
  • 免疫队列易感性与未接种随时间下降,风险人群中保持稳定。

临床怎么用

  • 临床应识别注射吸毒者、男男性行为者及乙肝或丙肝患者等高危成人,评估并补种甲肝疫苗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite national immunization efforts, including universal childhood hepatitis A (HepA) vaccination recommendations in 2006, hepatitis A virus (HAV)-associated outbreaks have increased in the United States. Unvaccinated or previously uninfected persons are susceptible to HAV infection, yet the susceptibility in the US population is not well known. METHODS: Using National Health and Nutrition Examination Survey 2007-2016 data, we estimated HAV susceptibility prevalence (total HAV antibody negative) among persons aged ≥2 years. Among US-born adults aged ≥20 years, we examined prevalence, predictors, and age-adjusted trends of HAV susceptibility by sociodemographic characteristics. We assessed HAV susceptibility and self-reported nonvaccination to HepA among risk groups and the "immunization cohort" (those born in or after 2004). RESULTS: Among US-born adults aged ≥20 years, HAV susceptibility prevalence was 74.1% (95% confidence interval, 72.9-75.3%) during 2007-2016. Predictors of HAV susceptibility were age group 30-49 years, non-Hispanic white/black, 130% above the poverty level, and no health insurance. Prevalences of HAV susceptibility and nonvaccination to HepA, respectively, were 72.9% and 73.1% among persons who reported injection drug use, 67.5% and 65.2% among men who had sex with men, 55.2% and 75.1% among persons with hepatitis B or hepatitis C, and 22.6% and 25.9% among the immunization cohort. Susceptibility and nonvaccination decreased over time among the immunization cohort but remained stable among risk groups. CONCLUSIONS: During 2007-2016, approximately three-fourths of US-born adults remained HAV susceptible. Enhanced vaccination efforts are critically needed, particularly targeting adults at highest risk for HAV infection, to mitigate the current outbreaks.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Yin S, Barker L, Ly KN, et al. Susceptibility to Hepatitis A Virus Infection in the United States, 2007-2016. Clin Infect Dis. 2020. PMID: 32193542. doi:10.1093/cid/ciaa298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。